China NT Pharma Terminates License Agreement With Abcentra for Monoclonal Antibody Technology; Shares Fall 10%
China NT Pharma Terminates License Agreement With Abcentra for Monoclonal Antibody Technology; Shares Fall 10%
中國泰凌醫藥終止與Abcentra公司的單克隆抗體技術許可協議;股價下跌10%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊